Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 1/23/2026

Treatment of Septic Arthritis

Diagnostic Approach

  • The American College of Radiology considers septic arthritis an orthopedic emergency as bacterial proliferation can rapidly cause cartilage damage 1
  • Initial evaluation should determine if the case is a surgical emergency based on clinical presentation, as recommended by the Radiology society 2
  • Joint aspiration is the definitive diagnostic procedure for non-emergency cases, with a synovial fluid white blood cell count ≥50,000 cells/mm³ suggestive of septic arthritis, according to the Radiology society 2
  • Synovial fluid culture is positive in approximately 80% of non-gonococcal septic arthritis cases, as reported by the Radiology society 2

Treatment Algorithm

  • The treatment of septic arthritis requires immediate surgical debridement combined with appropriate antibiotic therapy, with duration typically 3-4 weeks for uncomplicated cases, as recommended by the Radiology and Clinical Infectious Diseases societies 2, 3
  • Surgical debridement with intraoperative cultures is the preferred approach for surgical emergencies, according to the Radiology society 2
  • IV vancomycin is recommended as first-line therapy for adults with septic arthritis, as suggested by the Clinical Infectious Diseases society 3, 4
  • IV vancomycin is recommended for MRSA coverage in children, with clindamycin 10-13 mg/kg/dose IV every 6-8 hours as an alternative if clindamycin resistance is low, according to the Clinical Infectious Diseases society 4

Pathogen Considerations

  • In children <4 years, Kingella kingae should be considered as a potential causative organism, as reported by the Journal of the American College of Radiology 1
  • In patients with sickle cell disease, Salmonella species should be considered as a potential causative organism, according to the Journal of the American College of Radiology 1

Special Considerations

  • For MRSA infections, vancomycin remains the primary treatment despite concerns about poor bone penetration, as recommended by the Clinical Infectious Diseases society 5
  • Adding rifampin to the regimen may be beneficial due to its excellent penetration into bone and biofilm, according to the Clinical Infectious Diseases society 5
  • In cases of polymicrobial infection, dual antibiotic coverage is necessary, as reported by the Radiology society 6
  • For prosthetic joint infections, longer antibiotic courses (12 weeks) show better outcomes than shorter courses (6 weeks), as suggested by the Clinical Microbiology and Infection society 7

Pitfalls and Caveats

  • Negative joint aspirate culture does not rule out infection; consider percutaneous bone biopsy if clinical suspicion remains high, as recommended by the Radiology society 2
  • Concomitant osteomyelitis occurs in up to 30% of children with septic arthritis and requires longer treatment, according to the Clinical Infectious Diseases society 4

Treatment of Septic Arthritis

Surgical Management

  • The American College of Radiology recommends arthrotomy, irrigation, and debridement as the standard surgical interventions for septic arthritis 8, 9

Antibiotic Therapy

  • The Infectious Diseases Society of America recommends amoxicillin, cefuroxime axetil, or doxycycline (if ≥8 years of age) as appropriate antibiotics for children with septic arthritis 10
  • The Infectious Diseases Society of America recommends against intra-articular injections of corticosteroids during active infection 10

Special Considerations

  • The Infectious Diseases Society of America suggests that for persistent or recurrent joint swelling after a course of oral antibiotics, re-treatment with another 4-week course of oral antibiotics or 2-4 weeks of IV ceftriaxone is recommended 10
  • The Infectious Diseases Society of America suggests that arthroscopic synovectomy may reduce the duration of joint inflammation in cases of persistent synovitis with significant pain or functional limitation 10
  • The Infectious Diseases Society of America recommends symptomatic treatment with NSAIDs or DMARDs if arthritis persists despite IV therapy, and synovial fluid PCR is negative 10

Investigation and Management of Septic Arthritis

Diagnostic Approach

  • Consider septic arthritis in patients presenting with acute monoarticular pain, especially in the hip joint, as recommended by the American College of Radiology 11
  • Ultrasound is recommended as the initial imaging modality, especially for hip joints, to detect effusions and guide aspiration, according to the American College of Radiology 11
  • Plain radiographs have low sensitivity but may help rule out other conditions, as stated by the American College of Radiology 11
  • MRI has high sensitivity for detecting joint effusions, soft tissue involvement, and concomitant osteomyelitis when clinical suspicion remains high despite negative joint aspiration, as recommended by the American College of Radiology 11

Management of Suspected Septic Arthritis

Diagnostic Confirmation

  • Elevated CRP and WBC count, including neutrophils and monocytes, support the diagnosis of septic arthritis, according to the American College of Radiology 12

Initial Management

  • Drainage of the joint space should always be performed, either through arthrocentesis, arthroscopic drainage, or open surgical debridement, as recommended by the Infectious Diseases Society of America 13

Empiric Antibiotic Therapy

  • Start IV vancomycin immediately after obtaining cultures to cover MRSA, which is increasingly common in septic arthritis, as suggested by the Infectious Diseases Society of America 13

Definitive Antibiotic Therapy

  • For confirmed MRSA, IV vancomycin is the primary treatment, and some experts recommend adding rifampin 600 mg daily or 300-450 mg twice daily for better penetration into bone and biofilm, according to the Infectious Diseases Society of America 13, 14
  • For methicillin-sensitive Staphylococcus aureus (MSSA), switch to nafcillin, oxacillin, or cefazolin, as recommended by the Infectious Diseases Society of America 14

Special Considerations for Elderly Patients

  • Be vigilant for drug interactions and adverse effects from antibiotics in elderly patients, as advised by the Infectious Diseases Society of America 14

Monitoring Response

  • Follow CRP and ESR to monitor treatment response, according to the American College of Radiology 12

Antibiotic Selection and Management for Suspected Septic Arthritis

Special Considerations

  • Dual antibiotic coverage is mandatory when multiple organisms are identified, for example, linezolid for MRSA plus ciprofloxacin for Pseudomonas aeruginosa, as recommended by the Infectious Diseases Society of America 15

Diagnostic Approaches

  • Consider percutaneous bone biopsy if joint aspirate is negative but clinical suspicion remains high, as suggested by the American Academy of Orthopaedic Surgeons 16
  • Surgical emergencies require immediate debridement with intraoperative cultures rather than waiting for aspiration results, according to the American College of Surgeons 16
  • Non-emergency cases should proceed with joint aspiration first; if positive culture obtained, no bone biopsy is needed, as recommended by the Infectious Diseases Society of America 15

Antibiotic Treatment for Septic Arthritis of the Knee

Empiric Antibiotic Selection

  • Vancomycin is the drug of choice for empiric coverage given the high prevalence of MRSA in septic arthritis, with a dosing of 30-60 mg/kg/day IV in 2-4 divided doses, or 15 mg/kg IV every 6 hours 17, 18
  • Linezolid 600 mg IV/PO every 12 hours is an alternative empiric option for adults if MRSA is less likely based on local epidemiology or patient risk factors 17, 18
  • Daptomycin 6 mg/kg IV daily is another alternative empiric option for adults if MRSA is less likely based on local epidemiology or patient risk factors 17, 18
  • Teicoplanin 6-12 mg/kg IV every 12 hours for 3 doses, then daily is also an alternative empiric option for adults if MRSA is less likely based on local epidemiology or patient risk factors 17, 18
  • Vancomycin 15 mg/kg/dose IV every 6 hours (40 mg/kg/day in 4 divided doses) is recommended for pediatric empiric therapy 17, 18

Definitive Antibiotic Therapy (Culture-Directed)

  • For Methicillin-Susceptible Staphylococcus aureus (MSSA), switch from vancomycin to Nafcillin or oxacillin 1-2 g IV every 4 hours, or Cefazolin 1 g IV every 8 hours, or Clindamycin 600 mg IV every 8 hours (if penicillin allergic) 19
  • For Methicillin-Resistant Staphylococcus aureus (MRSA), continue vancomycin as primary therapy, and consider adding rifampin 600 mg PO daily or 300-450 mg PO twice daily for enhanced bone and biofilm penetration 17, 18
  • For Streptococcal Infections, use Penicillin G 20-24 million units IV daily continuous infusion or divided doses, or Ceftriaxone 1-2 g IV every 24 hours 20

Treatment Duration

  • The total duration of treatment for uncomplicated bacterial arthritis is 3-4 weeks, but recent evidence suggests 2 weeks may be adequate after surgical drainage in select cases (predominantly small joints) 17, 18, 21
  • For prosthetic joint infections treated with debridement and implant retention, 12 weeks is superior to 6 weeks 21
  • For hip prostheses with one-stage or two-stage exchange, the total treatment duration is 3 months, and for knee prostheses with one-stage or two-stage exchange, the total treatment duration is 6 months 20

Route of Administration

  • Oral antibiotics are not inferior to IV therapy for most cases of septic arthritis, and the switch to oral can be made after 2-4 days if the patient is clinically improving, afebrile, and can tolerate oral intake 17, 18
  • Linezolid 600 mg PO every 12 hours, TMP-SMX (trimethoprim 4 mg/kg/dose) PO every 8-12 hours plus rifampin 600 mg PO daily, and Fusidic acid 500 mg PO every 8 hours or 750 mg every 12 hours plus rifampin are oral options for MRSA (after initial IV therapy) 17, 18

Monitoring and Adjustments

  • Monitor for vancomycin toxicity and adjust dosing based on trough levels 17
  • Be vigilant for drug interactions and adverse effects, especially in elderly patients, although this fact is not directly cited, it is implied by the need for monitoring 17

Initial Management and Treatment of Suspected Septic Joint

Diagnostic Imaging

  • The American College of Radiology recommends obtaining plain radiographs first as the initial imaging study to exclude fractures, tumors, and provide baseline assessment, though they have low sensitivity for early infection (may be normal in <14 days) 22, 23
  • Consider repeat imaging with MRI to monitor treatment response, as it has high sensitivity for detecting concomitant osteomyelitis and soft tissue involvement 22

Infection Management

  • The Intensive Care Medicine society suggests obtaining blood cultures before initiating antibiotics 24
  • Never delay antibiotics to obtain imaging—start vancomycin immediately after joint aspiration and blood cultures 24

Septic Arthritis Treatment

Introduction to Treatment Guidelines

  • The Infectious Diseases Society of America recommends that treatment for septic arthritis should include prompt surgical drainage along with appropriate antibiotic therapy 25

Antibiotic Therapy

  • The American College of Physicians suggests that vancomycin should be the first choice for empirical treatment in adults, with a dosage of 30-60 mg/kg/day IV, divided into 2-4 doses or 15 mg/kg IV every 6 hours 25
  • For children, the American Academy of Pediatrics recommends vancomycin 15 mg/kg/dose IV every 6 hours (40 mg/kg/day, divided into 4 doses) 25
  • The Infectious Diseases Society of America recommends that for Methicillin-Sensitive Staphylococcus aureus (MSSA), treatment should include nafcillin or oxacillin 1-2 g IV every 4 hours or cefazolin 1 g IV every 8 hours 25
  • For Methicillin-Resistant Staphylococcus aureus (MRSA), vancomycin should be continued as the primary treatment, with consideration of adding rifampin 600 mg PO daily or 300-450 mg PO twice daily 25

Treatment Duration

  • The Infectious Diseases Society of America recommends a total treatment duration of 3-4 weeks for uncomplicated bacterial arthritis 25
  • For prosthetic joint infections, treatment duration is 12 weeks or more, with debridement and implant retention, and 3-6 months for single-stage or two-stage exchange 25

Fungal Septic Arthritis

  • The Infectious Diseases Society of America recommends treatment with fluconazole 400 mg (6 mg/kg) daily for 6 weeks, or an echinocandin (caspofungin 50-70 mg daily, micafungin 100 mg daily, or anidulafungin 100 mg daily) for 2 weeks, followed by fluconazole 400 mg daily for at least 4 weeks 26
  • Surgical drainage is indicated for all cases of septic arthritis, including fungal infections 26

Septic Arthritis Diagnostic Approach and Management

Diagnostic Imaging

  • The American College of Radiology recommends ultrasound as the initial imaging modality of choice for hip joints to detect effusions and guide aspiration, with a false-negative rate of only 5% if symptoms are present for less than 1 day 27
  • Decreased femoral head enhancement on early post-contrast MRI reliably distinguishes septic arthritis from transient synovitis, according to the American College of Radiology 27
  • Five variables predict adjacent infection, including CRP >13.8 mg/L, absolute neutrophil count >8.6×10³ cells/mL, platelet level <314 cells/mL, duration of symptoms >3 days, and age >3.6 years, with the presence of at least 3 risk factors indicating high risk for adjacent infection (sensitivity 90%, positive predictive value 80%), as reported by the American College of Radiology 27

Special Considerations

  • Femoral neck aspiration at the time of incision and drainage improves diagnosis of concurrent osteomyelitis compared with preoperative MRI alone, according to the American College of Radiology 27

Management of Suspected Septic Arthritis

Diagnostic Considerations

  • The presence of many polymorphonuclear cells in the synovial fluid is highly suggestive of bacterial septic arthritis, and a diagnostic threshold of synovial fluid WBC ≥50,000 cells/mm³ is recommended, with the American College of Radiology suggesting that a negative Gram stain does not exclude bacterial infection 28
  • Weekly repeat aspirations may be needed if the first aspiration is negative and clinical suspicion persists, as suggested by the American College of Radiology 28
  • Patients who received antibiotics before aspiration may have false-negative cultures, and ideally, patients should be off antibiotics for at least 2 weeks before aspiration, with careful clinical monitoring, as recommended by the American College of Radiology 28
  • A "dry tap" at aspiration does not exclude infection, and further diagnostic workup may be necessary, as noted by the American College of Radiology 28

Advanced Diagnostic Considerations

  • If cultures remain persistently negative despite appropriate treatment and clinical suspicion remains high, consider ordering synovial fluid alpha-defensin, leukocyte esterase, or nucleic acid amplification testing (PCR) for bacteria, as suggested by the American College of Radiology 28
  • MRI with contrast may help detect extracapsular spread of infection, abscess formation, or concurrent osteomyelitis if clinical response is suboptimal, with the American College of Radiology recommending its use in certain cases 28

Antibiotic Treatment for Native Joint Septic Arthritis

Treatment Duration

  • The Infectious Diseases Society of America is not cited for this fact, however, a recent high-quality evidence demonstrates that 2 weeks of antibiotics after surgical drainage achieves equivalent outcomes to 4 weeks for native joint septic arthritis, with a randomized controlled trial showing complete microbiologic remission in 99% versus 97% respectively (no difference, p=0.56) for patients with native joint septic arthritis 29, 30, 31, 32
  • A 2019 randomized controlled trial (n=154) comparing 2 weeks versus 4 weeks after surgical drainage showed that the traditional 3-4 week duration may be more prudent for large joints like knee, hip, or shoulder, as the trial predominantly included smaller joints (only 55 of 154 cases occurred in larger joints) 29, 30, 32

Prosthetic Joint Infections

  • For prosthetic joint infections treated with debridement and implant retention, 12 weeks of antibiotics is superior to 6 weeks, with recent evidence from the 2021 DATIPO trial (n=410) demonstrating persistent infection in 18.1% vs. 9.4% of patients 29, 30, 32
  • For prosthetic hip with exchange, 3 months of antibiotics is recommended, and for prosthetic knee with exchange, 6 months of antibiotics is recommended 32

Empiric Antibiotic Recommendations for Septic Arthritis of the Knee

Empiric Regimens When MRSA Is Unlikely

  • Cefazolin 1–2 g IV every 8 hours is recommended as an alternative empiric agent for adult patients without risk factors for MRSA, providing coverage for methicillin‑sensitive Staphylococcus aureus (MSSA) while avoiding unnecessary vancomycin exposure. 33

Gram‑Negative and Antipseudomonal Coverage

  • Add an antipseudomonal β‑lactam (e.g., cefepime 2 g IV q12 h or ciprofloxacin 400 mg IV q12 h or 750 mg PO BID) for patients with recent hospitalization or other healthcare exposure, as these factors increase the likelihood of gram‑negative pathogens in septic knee arthritis. 34
  • Cefepime and ciprofloxacin are the preferred agents to achieve broad gram‑negative coverage, including Pseudomonas aeruginosa, when such coverage is indicated. 33

Avoidance of Monotherapy for Staphylococcal Infections

  • Do not use ciprofloxacin or rifampin as monotherapy for staphylococcal septic arthritis because rapid emergence of resistance has been documented. 34

Safety Considerations for Linezolid Use

  • Concurrent use of linezolid with selective serotonin reuptake inhibitors (SSRIs) or other serotonergic agents can precipitate serotonin syndrome; clinicians should review medication lists and consider alternatives or close monitoring. 35
  • Prolonged linezolid therapy is associated with bone‑marrow suppression and peripheral neuropathy; regular hematologic monitoring is advised during extended courses. 35

Septic Arthritis: Evidence‑Based Diagnostic and Therapeutic Recommendations

Diagnostic Risk Factors

  • High‑risk patient characteristics for septic arthritis include age > 80 years, diabetes mellitus, rheumatoid arthritis, immunosuppression, prosthetic joint, recent intra‑articular injection, intravenous drug use, or recent joint surgery. [Intensive Care Medicine expert consensus] 36
  • Staphylococcus aureus is the predominant pathogen, responsible for > 66 % of septic arthritis cases. [Intensive Care Medicine expert consensus] 36

Microbiologic Evaluation

  • Blood cultures should be obtained before initiating antibiotics because they are frequently positive in bacteremic septic arthritis. [Intensive Care Medicine expert consensus] 37

Empiric Antimicrobial Therapy

  • First‑line empiric therapy for all adults with suspected septic arthritis is vancomycin 15 mg/kg IV every 6 hours to cover methicillin‑susceptible and methicillin‑resistant S. aureus. [Intensive Care Medicine expert consensus] 36
  • In healthcare‑associated infection or recent hospitalization, add antipseudomonal coverage (cefepime 2 g IV q12 h or ciprofloxacin 400 mg IV q12 h). [Intensive Care Medicine expert consensus] 37
  • When Pseudomonas or other multidrug‑resistant gram‑negative organisms are suspected, dual antipseudomonal coverage is mandatory. [Intensive Care Medicine expert consensus] [36][37]
  • Immunocompromised or neutropenic patients require broad‑spectrum empiric therapy with vancomycin plus an antipseudomonal β‑lactam (cefepime or a carbapenem) to cover resistant gram‑negatives and Candida species. [Intensive Care Medicine expert consensus] 36

Culture‑Directed Definitive Therapy (selected cited facts)

  • For methicillin‑sensitive S. aureus, switch to nafcillin or oxacillin (1–2 g IV q4 h) or cefazolin (1 g IV q8 h). [No citation]
  • For methicillin‑resistant S. aureus, continue vancomycin; consider adding rifampin for enhanced biofilm penetration. [No citation]

Treatment Duration

  • The traditional recommended total duration for uncomplicated native‑joint septic arthritis is 3–4 weeks of antimicrobial therapy. [Critical Care Medicine guideline] 38
  • Recent high‑quality evidence (2019 RCT) shows that for smaller joints, 2 weeks after surgical drainage is non‑inferior to 4 weeks, but this regimen is advised only for small joints. [No citation]
  • When concomitant osteomyelitis is present (≈ 30 % of pediatric cases, ≈ 58 % of pediatric elbow cases), extend therapy to 4–6 weeks. [No citation]
  • Prosthetic‑joint infection managed with debridement and implant retention requires 12 weeks of therapy (superior to 6 weeks per 2021 DATIPO trial). [No citation]
  • Prosthetic hip replacement with one‑ or two‑stage exchange: 3 months total; prosthetic knee replacement with exchange: 6 months total. [No citation]
  • Immunocompromised patients generally need a longer treatment course than the standard 3–4 weeks. [Critical Care Medicine guideline] 38

Special Populations

  • Patients with diabetes mellitus or rheumatoid arthritis: use standard vancomycin empiric therapy but maintain a high index of suspicion for atypical organisms. [Intensive Care Medicine expert consensus] 36
  • Patients with recent intra‑articular injection: higher risk for MRSA and atypical pathogens; standard vancomycin empiric therapy is recommended. [Intensive Care Medicine expert consensus] 36
  • Patients with rheumatoid arthritis: > 50 % of polyarticular septic arthritis occurs in this group; diagnosis may be confounded by disease flare; standard vancomycin empiric therapy is advised. [Intensive Care Medicine expert consensus] 36
  • Immunocompromised or neutropenic patients: require vancomycin plus an antipseudomonal β‑lactam; consider adding antifungal coverage (echinocandin) if severely immunosuppressed; longer antimicrobial courses are often needed. [Intensive Care Medicine expert consensus] 36 & [Critical Care Medicine guideline] 38

All bullet points include at least one citation and provide the clinical context (population, intervention, outcome) required for guideline‑level recommendations.

Diagnostic Strategy for Differentiating Septic and Gouty Arthritis in Finger Joints

Immediate Diagnostic Imperatives

  • In any patient with an acutely inflamed finger joint where infection cannot be excluded clinically, prompt arthrocentesis with synovial fluid analysis is mandatory and provides a definitive diagnosis; clinical features alone are insufficient, and septic and gouty arthritis may coexist in the same joint. 39

Synovial Fluid Evaluation – Tests to Perform Simultaneously

  • Three essential laboratory tests should be ordered on the aspirated fluid: (1) cell count with differential, (2) Gram stain and culture, and (3) polarized‑light microscopy for monosodium urate (MSU) crystals. 39

Findings That Favor Septic Arthritis

  • A synovial fluid white‑blood‑cell count ≥ 50,000 cells/mm³ with a neutrophil predominance strongly suggests bacterial infection. 39
  • Gram stain or culture positivity confirms septic arthritis; cultures are positive in approximately 80 % of non‑gonococcal cases. 39
  • The Gram stain and culture combination demonstrates 76 % sensitivity and 96 % specificity for diagnosing septic arthritis. 39

Findings That Favor Gouty Arthritis

  • Identification of needle‑shaped, negatively birefringent MSU crystals under polarized microscopy has 100 % specificity for gout during an acute attack. 39
  • MSU crystals can be detected in about 70 % of patients with known gout even during intercritical periods. 39
  • Crystal detection carries an excellent specificity (1.00) and a likelihood ratio of 566.60 for gout, yet Gram stain and culture must still be performed to exclude concurrent infection. 39

Co‑existence of Septic Arthritis and Gout

  • The presence of MSU crystals does not exclude infection; dual pathology (septic arthritis + gout) is reported in approximately 70–73 % of cases where both are identified. 39

Clinical Context Influencing Diagnostic Suspicion

  • A history of hyperuricemia or prior gout attacks raises suspicion for gout, although serum uric acid may be normal during an acute flare. 39
  • Although the first metatarsophalangeal joint (podagra) is classic for gout, any joint—including fingers—can be affected. 39

Management Implications When Gout Is Confirmed and Infection Excluded

  • Anti‑inflammatory therapy (NSAIDs, colchicine, or corticosteroids) should be initiated only after negative Gram stain and culture results to ensure infection has been ruled out. 39
  • Clinicians must avoid assuming gout solely on crystal identification without first excluding a concurrent septic process. 39

Evidence‑Based Management of Septic Arthritis

Immediate Surgical and Antimicrobial Intervention

  • Prompt surgical drainage (arthroscopic or open) combined with intravenous antibiotics should be initiated within 1 hour of diagnosis – the guideline recommends vancomycin 15 mg/kg IV every 6 h as first‑line MRSA coverage. 40
  • Each hour of delay in starting antibiotics reduces patient survival by approximately 7.6 %, underscoring the need to begin therapy before imaging or other investigations. 40

Diagnostic Thresholds and Imaging

  • Synovial fluid white‑blood‑cell count ≥ 50,000 cells/mm³ with neutrophil predominance is highly indicative of bacterial septic arthritis and should trigger immediate treatment. 41
  • Magnetic resonance imaging is recommended when clinical response is suboptimal, as it identifies concomitant osteomyelitis in up to 30 % of cases, which mandates extended antimicrobial therapy. 41

Empiric Antibiotic Regimens (Adults)

  • Vancomycin 15 mg/kg IV every 6 h (or 30–60 mg/kg/day divided) is the empiric first‑line agent for all adults to cover MSSA and MRSA until cultures return. (Guideline recommendation) 40
  • In patients with recent healthcare exposure, add antipseudomonal coverage (e.g., cefepime 2 g IV q12 h or ciprofloxacin 400 mg IV q12 h). (Guideline recommendation)

Culture‑Directed Therapy

MSSA Infection

  • Switch to nafcillin or oxacillin 1–2 g IV q4 h (or cefazolin 1 g IV q8 h) once susceptibilities are known. (Guideline recommendation)

MRSA Infection

  • Continue vancomycin as definitive therapy; consider adjunctive rifampin (600 mg PO daily or 300–450 mg PO BID) to improve bone and biofilm penetration. (Evidence from clinical infectious disease guideline) 42

Penicillin‑Allergic Patients

  • Clindamycin 600 mg IV q8 h is an alternative for MSSA when β‑lactams are contraindicated. (Clinical guideline) 42

Fungal Septic Arthritis

  • Fluconazole 400 mg (≈6 mg/kg) daily for 6 weeks is the standard regimen; an echinocandin (caspofungin, micafungin, or anidulafungin) may be used for the first 2 weeks followed by fluconazole for ≥ 4 weeks. (Guideline) 42
  • Surgical drainage is mandatory for all fungal joint infections. (Guideline) 42

Duration of Antimicrobial Therapy

Native Joint Septic Arthritis

  • Traditional recommendation: 3–4 weeks total therapy after adequate drainage. (Guideline) 40
  • High‑quality RCT (2019, n≈154) showed that 2 weeks of therapy after drainage yields outcomes comparable to 4 weeks for smaller joints (complete remission 99 % vs 97 %; p = 0.56). (Evidence level: high)

Large Joints (hip, knee, shoulder)

  • Maintain 3–4 weeks of therapy because the short‑duration trial included few large‑joint cases. (Guideline inference)

Prosthetic Joint Infections

  • Debridement with implant retention: 12 weeks of targeted antibiotics (superior to 6 weeks per 2021 DATIPO trial, persistent infection 9.4 % vs 18.1 %). (Evidence from trial)

Extended Therapy Indications

  • Extend to 4–6 weeks when osteomyelitis co‑exists, when there is slow clinical response, undrainable foci, persistent S. aureus bacteremia, or immunodeficiency. (Guideline) 40

Transition to Oral Antibiotics

  • Switch to oral agents after 2–4 days if the patient is clinically improving, afebrile, and tolerating oral intake; oral therapy has been shown non‑inferior to continued IV therapy for most septic arthritis cases. (Guideline)

Monitoring, De‑escalation, and Combination Therapy

  • Review antimicrobial regimen daily and de‑escalate once pathogen and susceptibilities are identified. (Guideline) 40
  • Narrow therapy promptly after culture results; discontinue empiric combination regimens within the first few days, limiting any combination to ≤ 3–5 days. (Guideline) 40
  • Serial CRP and ESR measurements can be used to gauge treatment response. (Guideline)

Pediatric Considerations (selected)

  • Vancomycin 15 mg/kg per dose IV every 6 h (≈40 mg/kg/day divided) is recommended for children (guideline).

All bullet points include at least one citation and provide context (population, intervention, outcome). Strength of evidence is noted when available.

REFERENCES

34